跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NUBEQA darolutamide 300 mg tablet bottle - TGA Drug Approval Details
Approvals
/
TGA
/
NUBEQA darolutamide 300 mg tablet bottle
Approved
STANDARD
NUBEQA darolutamide 300 mg tablet bottle
Bayer Australia Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
04d2205bcca952f1
Company
Bayer Australia Ltd
Type
Standard
Approval Details
Approval Id
04d2205bcca952f1
Product Name
NUBEQA darolutamide 300 mg tablet bottle
Artg Id
317242
Artg Name
NUBEQA darolutamide 300 mg tablet bottle
Sponsor
Bayer Australia Ltd
Company Detail Path
/organization/bayer-australia-ltd
Artg Date
2020-02-26
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-CMI-01415-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-PI-01276-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
04d2205bcca952f1
Type
Standard
Back to TGA Approvals